C7 Proteins, Antibodies, cDNA Clones, ELISA Kits Research Reagents

All C7 reagents are produced in house and quality controlled, including 4 C7 Antibody, 1 C7 ELISA, 15 C7 Gene, 2 C7 Lysate, 2 C7 Protein, 1 C7 qPCR. All C7 reagents are ready to use.

C7 Protein (2)

    C7 Antibody (4)

      C7 ELISA Kit & Match Antibody ELISA Pair Set (1)

      C7 cDNA Clone (15)


      In cloning vector

      In lentiviral vector

      C7 qPCR Primer (1)

      C7 Lysate (2)

        More Product Popular With Customers

        C7 Background

        Complement component 7 is a component of the complement system. It belongs to the complement C6/C7/C8/C9 family. It contains 1 EGF-like domain, 1 LDL-receptor class A domain, 1 MACPF domain, 2 Sushi (CCP/SCR) domains and 2 TSP type-1 domains. Complement component 7 serves as a membrane anchor. It participates in the formation of Membrane Attack Complex (MAC). People with C7 deficiency are prone to bacterial infection. It is a constituent of MAC that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. Defects in C7 are a cause of complement component 7 deficiency (C7D). A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections, predominantly by Neisseria gonorrhoeae or Neisseria meningitidis.

        C7 References

        • Bossi F, et al. (2009) C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood. 113(15):3640-8.
        • Kuijpers TW, et al. (2010) Complement factor 7 gene mutations in relation to meningococcal infection and clinical recurrence of meningococcal disease. Mol Immunol. 47(4):671-7.
        • Thomas AD, et al. (2012) Characterization of a large genomic deletion in four Irish families with C7 deficiency. Mol Immunol. 50(1-2):57-9.

        Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.